A novel, orally administered drug candidate, TTP488, has demonstrated clinical evidence of slowing of cognitive decline over 18 months of therapy in patients with mild to moderate Alzheimer's disease.
URL: http://www.news-medical.net/news/20121030/TTP488-slows-cognitive-decline-in-patients-with-mild-to-moderate-Alzheimers.aspx
No comments:
Post a Comment